Novartis International AG (VTX:NOVN) New Study First To Confirm Sandostatin® LAR® Controls Tumor Growth In Patients With Rare Gastrointestinal Tumors
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------










